Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma.
Cancer reports (Hoboken, N.J.)（2023）
摘要
Thus, even MM patients who respond adequately to vaccination are likely to require more frequent booster doses than the general population.
更多查看译文
关键词
COVID-19,SARS-CoV-2,antibodies,half-life,multiple myeloma,vaccination
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要